Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Novo Nordisk A/S

Start price
Target price
Perf. (%)
€86.20
20.01.22
€125.00
20.01.23
47.29%
02.01.23

buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€6.21
27.12.21
€8.00
27.12.22
66.67%
28.12.22

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€208.25
27.12.21
€215.00
27.12.22
23.82%
28.12.22

Could be worthwhile Investment >10% per year
buy
Horizon Pharma plc

Start price
Target price
Perf. (%)
€61.22
07.09.22
€100.00
31.12.25
73.41%
14.12.22

Could be very worthwhile Investment >20% year
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.53
12.12.22
€5.00
12.12.23
-33.60%
12.12.22

buy
Oncodesign S.A.

Start price
Target price
Perf. (%)
€8.61
08.12.21
€10.00
08.12.22
65.85%
09.12.22

Could be worthwhile Investment >10% per year
buy
Oncopeptides AB

Start price
Target price
Perf. (%)
€1.02
02.12.21
€1.50
02.12.22
56.67%
03.12.22

Could be worthwhile Investment >10% per year
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€140.70
27.11.21
€160.00
27.11.22
21.35%
28.11.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Astrazeneca ADR

Start price
Target price
Perf. (%)
€50.60
27.11.21
€60.00
27.11.22
26.48%
28.11.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€533.60
09.11.21
€600.00
09.11.22
38.91%
10.11.22

Could be worthwhile Investment >10% per year
Evotec SE

Start price
Target price
Perf. (%)
€39.96
03.11.21
€33.00
03.11.22
-53.95%
04.11.22

buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.40
01.11.21
€15.00
01.11.22
79.03%
02.11.22

Could be worthwhile Investment >10% per year
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€338.70
07.10.22
€350.00
07.10.23
7.12%
29.10.22

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.87
15.05.22
€68.00
15.05.23
32.12%
28.10.22

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Immunic Inc.

Start price
Target price
Perf. (%)
€2.86
21.10.22
€2.50
21.10.23
-23.12%
22.10.22

Genoway S.A. Inh.

Start price
Target price
Perf. (%)
€4.37
07.11.21
€4.10
07.11.22
-19.68%
22.10.22

Could be worthwhile Investment >10% per year
Virbac S.A.

Start price
Target price
Perf. (%)
€401.50
07.11.21
€385.00
07.11.22
-38.36%
22.10.22

Could be worthwhile Investment >10% per year
Advicenne

Start price
Target price
Perf. (%)
€7.24
17.10.21
€6.00
17.10.22
-43.92%
18.10.22

Could be worthwhile Investment >10% per year
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.50
01.10.22
€5.00
01.10.23
-70.29%
15.10.22

buy
Bayer AG

Start price
Target price
Perf. (%)
€43.96
06.12.21
€48.00
12.10.22
12.32%
13.10.22

Could be worthwhile Investment >10% per year
buy
Flexion Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.25
27.09.21
€8.00
27.09.22
53.33%
28.09.22

Inventiva SA

Start price
Target price
Perf. (%)
€11.54
10.09.21
€8.00
10.09.22
-63.65%
11.09.22

Could be worthwhile Investment >10% per year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€29.94
20.10.21
€35.00
31.12.23
65.15%
05.08.22

Could be very worthwhile Investment >20% year
buy
Global Blood Therapeutics Inc

Start price
Target price
Perf. (%)
€33.09
30.10.21
€45.00
31.12.23
94.65%
05.08.22

Could be very worthwhile Investment >20% year
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€152.65
16.11.21
€200.00
31.01.25
36.59%
03.08.22

Could be worthwhile Investment >10% per year